Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4    Pharmaceuticals 5    Pharmaceuticals 6       - Companies  << You are in This Category #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   # 2006 Financings: IPOs and Pharmas Acquisitions of Private (IPO-less) C... static version printer friendly pdf version 2006 Industry Dynamics: Lessons to Be Learned static version printer friendly pdf version ^ Top A Abbott Laboratories: Pipeline - Products - Performance - Potential static version printer friendly Acambis PLC – Pharmatrack static version printer friendly pdf version Allergan: Performance, Products, Pipeline and Potential static version printer friendly Altana: PharmaVitae Profile static version printer friendly pdf version Arena Pharmaceuticals, Inc. - Pharmatrack static version printer friendly pdf version AstraZeneca: Pipeline, Products, Performance, Potential static version printer friendly pdf version ^ Top B Barr Pharmaceuticals Inc. - Pharmatrack static version printer friendly pdf version Bayer: Performance, Products, Pipeline and Potential static version printer friendly Biologic Drugs to Drive Pharmaceutical Market Growth static version printer friendly pdf version BioMarin Pharmaceuticals - Pharmatrack static version printer friendly Biotechnology 2006: Winning Companies and Pipelines static version printer friendly Biotechnology Company Growth Strategies static version printer friendly Bristol-Myers Squibb Company - Pharmatrack  static version printer friendly ^ Top C C V Therapeutics, Inc. - PharmaTrack static version printer friendly Candela Corporation - Pharmatrack static version printer friendly Cell Therapeutics Inc - PharmaTrack  static version printer friendly Cephalon Inc - PharmaTrack  static version printer friendly Changing Market Dynamics Fuel the Evolution of Specialty Pharma static version printer friendly Chugai: Pipeline, Products, Performance and Potential static version printer friendly pdf version Clinical Laboratory Testing Market Overview 2006 static version printer friendly pdf version CollaGenex Pharmaceuticals, Inc. - Pharmatrack static version printer friendly Columbia Laboratories, Inc. - Pharmatrack static version printer friendly Combivir And Trizivir Case Study: The Role Of Pricing In Achieving Suc... static version printer friendly pdf version Commercial Insight: Antithrombotics - Sanofi-Aventis the Dominant Play... static version printer friendly Competitor Analysis: C5a-R Antagonists static version printer friendly pdf version Curative Health Services Inc. - Pharmatrack static version printer friendly Cytogen Corporation - PharmaTrack static version printer friendly pdf version ^ Top D Daiichi Sankyo: Pipeline, Products, Performance and Potential static version printer friendly Datascope Corporation - Pharmatrack static version printer friendly Diagnostica and Analys Service AB static version printer friendly Directory of Clinical Research Companies in India static version printer friendly pdf version Does the Treatment of Huntington's Disease Represent a Commercial Oppo... static version printer friendly pdf version Drug Delivery 2000: A Key Company and Market Analysis static version printer friendly ^ Top E Eli Lilly and Company - Pharmatrack static version printer friendly Emerging Blockbusters: 2009's Most Promising Drugs and the Future of t... static version printer friendly pdf version Executing Change in the Pharma Industry - Prescription for Pfizer static version printer friendly pdf version ^ Top F Forest Laboratories Inc - Pharmatrack static version printer friendly ^ Top G Generic Series: Benchmarking Patent Expiries - Key Factors Affecting B... static version printer friendly pdf version Genetech Inc - Pharmatrack  static version printer friendly Genta-Aventis Case Study: Failing Strategies Within Late Stage Vertica... static version printer friendly Gilead Sciences: Pipeline - Products - Performance - Potential static version printer friendly pdf version Gilead: PharmaVitae Profile static version printer friendly pdf version Gilead: PharmaVitae Profile 2005 static version printer friendly GlaxoSmithKline - Pharmatrack  static version printer friendly GlaxoSmithKline: Pipeline, Products, Performance and Potential static version printer friendly pdf version Global Cancer Focus Company Directory static version printer friendly pdf version ^ Top H H1 2001 Results: Financial Results of the Top 12 Pharmaceutical Compan... static version printer friendly pdf version Hi-Tech Pharmacal Co. Inc. - PharmaTrack static version printer friendly pdf version ^ Top I ICON Plc. - PharmaTrack static version printer friendly Immucor Inc - Pharmatrack static version printer friendly Inkine Pharmaceutical Company Inc. - PharmaTrack static version printer friendly Inverness Medical Innovations Inc - Competitor Report static version printer friendly Ipsen: Pharmavitae Profile 2005 static version printer friendly ^ Top J Japanese Pharma Companies Merger Analysis Tool static version printer friendly pdf version Japanese Pharma Companies Comparator Tool static version printer friendly pdf version Japanese Pharma To 2010 - Imminent Transition Towards Globalization Ne... static version printer friendly Johnson & Johnson - Pharmatrack static version printer friendly Johnson & Johnson: Performance, Products, Pipeline and Potential static version printer friendly pdf version ^ Top K Kendle International Inc. - PharmaTrack static version printer friendly Kyowa Hakko: Performance, Products, Pipeline and Potential static version printer friendly pdf version ^ Top L Leading Biotech Companies: US and Europe 2000 static version printer friendly Lipitor Case Study: Lifecycle Management Strategies static version printer friendly ^ Top M Maven Semantic Healthcare Database static version printer friendly pdf version MedImmune Inc.: PharmaVitae Profile static version printer friendly pdf version Menarini: Pharmavitae Profile 2005 static version printer friendly pdf version Merck KGaA: Pipeline, Products, Performance and Potential static version printer friendly pdf version Mergers, Acquisitions and Licensing to Continue Drive Industry Growth static version printer friendly pdf version Merit Medical Systems Inc - Deals and Alliances Report static version printer friendly Monoclonal Antibodies Report Part II: Companies - Holding mAbs in port... static version printer friendly pdf version ^ Top N Neoforma Inc - Financial Report static version printer friendly ^ Top O Orphan Medical Inc. - PharmaTrack static version printer friendly pdf version ^ Top P Pacific Health Systems Inc. static version printer friendly pdf version Pfizer And Astrazeneca Case Studies: Enhancing Sales Team Tactics static version printer friendly Pfizer Inc - Pharmatrack static version printer friendly Pharmaceutical Companies Merger Analysis Tool static version printer friendly Pharmaceutical Company Comparator Tool - Global Analysis static version printer friendly Pharmaceutical Product Development, Inc. - PharmaTrack static version printer friendly pdf version Pharmaceutical Product Relaunch: Preserving Market Share through Line ... static version printer friendly pdf version Pharmacoeconomics and Health Outcomes: Driving Formulary Access and Re... static version printer friendly pdf version PharmaDeals® Deal Making Spotlight on GSK static version printer friendly PharmaDeals® Deal Making Spotlight on Johnson & Johnson static version printer friendly PharmaDeals® Deal Making Spotlight on Novartis static version printer friendly pdf version PharmaDeals®: Deal Making Spotlight on Pfizer static version printer friendly pdf version PharmaDeals®: Deal Making Spotlight on Sanofi-Aventis static version printer friendly pdf version PharmaVitae 2004: Almirall Global & US Analysis static version printer friendly PharmaVitae 2004: Almirall Global Analysis static version printer friendly PharmaVitae 2004: Amgen Global & US Analysis static version printer friendly PharmaVitae 2004: Amgen Global Analysis static version printer friendly PharmaVitae 2004: Celltech Global & US Analysis static version printer friendly PharmaVitae 2004: Celltech Global Analysis static version printer friendly PharmaVitae 2004: Daiichi Pharmaceuticals Global Analysis static version printer friendly PharmaVitae 2004: Daiichi Pharmaceuticals Global and US Analysis static version printer friendly PharmaVitae 2004: Eisai Global & US Analysis static version printer friendly PharmaVitae 2004: Eisai Global Analysis static version printer friendly PharmaVitae 2004: Eli Lilly Global & US Analysis static version printer friendly PharmaVitae 2004: Eli Lilly Global Analysis static version printer friendly PharmaVitae 2004: Forest Global & US Analysis static version printer friendly PharmaVitae 2004: Forest Global Analysis static version printer friendly PharmaVitae 2004: Fujisawa Global & US Analysis static version printer friendly PharmaVitae 2004: Fujisawa Global Analysis static version printer friendly PharmaVitae 2004: Genentech Global Analysis static version printer friendly pdf version PharmaVitae 2004: Genentech Global and US Analysis static version printer friendly pdf version PharmaVitae 2004: Genzyme Global & US Analysis static version printer friendly pdf version PharmaVitae 2004: Genzyme Global Analysis static version printer friendly pdf version PharmaVitae 2004: Ipsen Global & US Analysis static version printer friendly PharmaVitae 2004: Ipsen Global Analysis static version printer friendly PharmaVitae 2004: Mitsubishi Pharma Global & US Analysis static version printer friendly pdf version PharmaVitae 2004: Novartis Global & US Analysis static version printer friendly PharmaVitae 2004: Novartis Global Analysis static version printer friendly PharmaVitae 2004: Pfizer Global & US Analysis static version printer friendly pdf version PharmaVitae 2004: Pfizer Global Analysis static version printer friendly PharmaVitae 2004: Sankyo Global & US Analysis static version printer friendly pdf version Pharmavitae 2004: Sankyo Global Analysis static version printer friendly pdf version PharmaVitae 2004: Sanofi-Aventis Global & US Analysis static version printer friendly PharmaVitae 2004: Sanofi-Aventis Global Analysis static version printer friendly pdf version PharmaVitae 2004: Serono Global & US Analysis static version printer friendly PharmaVitae 2004: Serono Global Analysis static version printer friendly PharmaVitae 2004: Servier Global & US Analysis static version printer friendly PharmaVitae 2004: Servier Global Analysis static version printer friendly PharmaVitae 2004: Shionogi Global & US Analysis static version printer friendly PharmaVitae 2004: Shionogi Global Analysis static version printer friendly PharmaVitae 2004: Takeda Global & US Analysis static version printer friendly PharmaVitae 2004: Takeda Global Analysis static version printer friendly PharmaVitae 2004: Wyeth Global Analysis static version printer friendly PharmaVitae 2004: Wyeth Global and US Analysis static version printer friendly PharmaVitae 2005: Almirall Global Analysis static version printer friendly PharmaVitae 2005: Almirall Global and US Analysis static version printer friendly PharmaVitae 2005: Altana Global and US Analysis static version printer friendly PharmaVitae 2005: Amgen Global Analysis static version printer friendly PharmaVitae 2005: Amgen Global and US Analysis static version printer friendly Pharmavitae 2005: Forest Global Analysis static version printer friendly Pharmavitae 2005: Forest Global And US Analysis static version printer friendly Pharmavitae 2005: Novartis Global & US Analysis static version printer friendly Pharmavitae 2005: Novartis Global Analysis static version printer friendly Pharmavitae 2005: Pfizer Global Analysis static version printer friendly Pharmavitae 2005: Pfizer Global And US Analysis static version printer friendly pdf version Pharmavitae 2005: Sanofi-Aventis Global Analysis static version printer friendly Pharmavitae 2005: Sanofi-Aventis Global And US Analysis static version printer friendly Pharmavitae 2005: Serono Global & US Analysis static version printer friendly Pharmavitae 2005: Serono Global Analysis static version printer friendly Pharmavitae 2005: Shire Global Analysis static version printer friendly pdf version PharmaVitae Company Comparator Tool - Global and US Analysis static version printer friendly pdf version PharmaVitae Merger Analysis Tool static version printer friendly PharmaWatch Health Round-up static version printer friendly PharmaWatch: Biotechnology static version printer friendly PharmaWatch: Cancer static version printer friendly PharmaWatch: CNS static version printer friendly Protherics PLC - Competitor Report static version printer friendly ^ Top R Recordati: Pharmavitae Profile 2005 static version printer friendly pdf version Regional Sales 2000: A Company and Therapeutic Market Analysis static version printer friendly Reputation Monitor: the Pharmaceutical Industry static version printer friendly Roche Case Study: Becoming A Targeted Medicine Player static version printer friendly Roche Holding - Pharmatrack static version printer friendly ^ Top S Sanofi-Synthelabo - Pharmatrack static version printer friendly Santarus, Inc. - SWOT Analysis static version printer friendly pdf version Savient Pharmaceuticals Inc. - PharmaTrack static version printer friendly Schering Plough Corporation - Pharma Track static version printer friendly Schering-Plough: Pipeline - Products - Performance - Potential static version printer friendly pdf version Schwarz: Pharmavitae Profile 2005 static version printer friendly pdf version Serologicals - Pharmatrack static version printer friendly Serono SA - Pharmatrack static version printer friendly Serono: PharmaVitae Profile static version printer friendly pdf version Servier: Pharmavitae Profile 2005 static version printer friendly Shire: Pipeline, Products, Performance and Potential static version printer friendly pdf version State of the Pharmaceutical Industry, 2007 static version printer friendly pdf version Symbicort Case Study: Creating Differentation In Combination Products static version printer friendly pdf version ^ Top T Takeda: PharmaVitae Profile static version printer friendly pdf version Takeda: Pipeline, Products, Performance and Potential static version printer friendly Teva Pharmaceuticals Industries Ltd. - PharmaTrack static version printer friendly The Quigley Corporation - Pharmatrack static version printer friendly The Top 100 Drugs of 2000: A Company and Therapeutic Market Analysis static version printer friendly The Top 100 European Manufacturers Of Finished Pharmaceuticals static version printer friendly pdf version The Top 50 Pharmaceutical Manufacturing Companies In Ireland static version printer friendly The Top Five Global Pharma Companies; Where they are Now and Where the... static version printer friendly pdf version The War On Cancer - 2nd Edition static version printer friendly Top 10 Pharmaceutical Companies: Media Monitor static version printer friendly pdf version Trends in the Commercialization of Biomarkers: Tests and Companies static version printer friendly pdf version ^ Top U United Therapeutics Corporation – PharmaTrack static version printer friendly ^ Top V Vistacare Inc - Pharmatrack static version printer friendly Vivus Inc. - PharmaTrack static version printer friendly ^ Top W Watson Pharmaceuticals Inc. - PharmaTrack static version printer friendly What to Do When the R&D Pipeline Runs Dry static version printer friendly pdf version Who Owns You? The Corporate Gold Rush to Patent Your Genes static version printer friendly pdf version Wyeth: Performance, Products, Pipeline and Potential static version printer friendly Wyeth: Pharmavitae Profile 2005 static version printer friendly ^ Top Z Zetia & Vytorin Case Study: Successfully Challenging The Statin Marke... static version printer friendly pdf version All rights reserved. © copyright 2008 Research and Markets Terms and conditions Privacy Policy